Editorial
Copyright ©The Author(s) 2024. Published by Baishideng Publishing Group Inc. All rights reserved.
World J Diabetes. Apr 15, 2024; 15(4): 598-605
Published online Apr 15, 2024. doi: 10.4239/wjd.v15.i4.598
Pancreatic surgery and tertiary pancreatitis services warrant provision for support from a specialist diabetes team
Vasileios K Mavroeidis, Jennifer Knapton, Francesca Saffioti, Daniel L Morganstein
Vasileios K Mavroeidis, Department of HPB Surgery, Bristol Royal Infirmary, University Hospitals Bristol and Weston NHS Foundation Trust, Bristol BS2 8HW, United Kingdom
Vasileios K Mavroeidis, Department of Gastrointestinal Surgery, Southmead Hospital, North Bristol NHS Trust, Bristol BS10 5NB, United Kingdom
Vasileios K Mavroeidis, Jennifer Knapton, Department of Academic Surgery, Royal Marsden NHS Foundation Trust, London SW3 6JJ, United Kingdom
Francesca Saffioti, Department of Gastroenterology and Hepatology, Oxford University Hospitals NHS Foundation Trust, Oxford OX3 9DU, United Kingdom
Francesca Saffioti, UCL Institute for Liver and Digestive Health, University College London, London NW3 2PF, United Kingdom
Daniel L Morganstein, Department of Endocrinology, Chelsea and Westminster Hospital NHS Foundation Trust, London SW10 9NH, United Kingdom
Daniel L Morganstein, Department of Gastrointestinal Unit, Royal Marsden NHS Foundation Trust, London SW3 6JJ, United Kingdom
Author contributions: Mavroeidis VK conceptualised and designed the study, did the literature search and drafted the original manuscript; Knapton J and Saffioti F contributed to the literature search and revisions; Morganstein DL made critical revisions; all authors prepared the final draft and approved the final version.
Conflict-of-interest statement: Morganstein DL reports personal fees from Bristol Meyer Squibb, personal fees from MSD, personal fees from Roche. All other authors declare no conflict of interests for this article.
Open-Access: This article is an open-access article that was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution NonCommercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: https://creativecommons.org/Licenses/by-nc/4.0/
Corresponding author: Vasileios K Mavroeidis, MD, MSc, FRCS, FACS, FICS, FSSO, MFSTEd, MICR, Academic Research, Surgeon, Department of HPB Surgery, Bristol Royal Infirmary, University Hospitals Bristol and Weston NHS Foundation Trust, Upper Maudlin St, Bristol BS2 8HW, United Kingdom. vasileios.mavroeidis@nhs.net
Received: December 30, 2023
Peer-review started: December 30, 2023
First decision: January 16, 2024
Revised: January 30, 2024
Accepted: March 1, 2024
Article in press: March 1, 2024
Published online: April 15, 2024
Processing time: 103 Days and 4.9 Hours
Core Tip

Core Tip: In this editorial, we discuss the complex associations between diabetes mellitus and pancreatic/periampullary disease in the context of pancreatic surgery and overall management of complex pancreatitis, highlighting the consequential needs and the indispensable role of specialist diabetes teams in support of tertiary pancreatic services. In these settings, there is accumulating evidence that adequate glycaemic control at all stages improves outcomes, and that early involvement of specialist diabetes teams is of paramount importance to ensure a holistic management approach. The design of specific guidelines for the glycaemic management in these settings is warranted.